Clinical Trials Logo

Clinical Trial Summary

Primary objectives • To check for sensitivity and specificity of cystic fluid glucose level for differentiating the mucinous & non mucinous pancreatic cyst Secondary Objectives: - comparison of cystic fluid tumor makers like CEA with cystic fluid glucose level. - Check for cutoff value of cystic fluid glucose level for diagnosis of mucinous pancreatic cyst in Indian population.


Clinical Trial Description

For patients who have a pancreatic cyst bigger than 2cm found during a radiology exam, they will undergo an Endoscopic ultrasound exam to check the cyst and fluid will be collected for testing, including glucose, CEA (carcinoembryonic antigen), and amylase. A biopsy will be done if possible. We will analyze how well the glucose level in the fluid can tell us if the cyst is cancerous or not, using CEA level, EUS findings, and amylase level as the standard. This is an observational study, and patients will receive standard medical treatment. The study won't change the treatment they receive. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06189339
Study type Observational
Source Asian Institute of Gastroenterology, India
Contact Mona Aggarwal, MD
Phone 8851352374
Email drmona.11191@gmail.com
Status Not yet recruiting
Phase
Start date January 24, 2024
Completion date December 20, 2025